Patentability of New Form, Use or Property – Section 3(d)
Section 3(d) of the Indian Patents Act limits patentability for new forms or uses of known substances unless enhanced efficacy is proven. The Novartis case illustrates how courts…
201 articles
Section 3(d) of the Indian Patents Act limits patentability for new forms or uses of known substances unless enhanced efficacy is proven. The Novartis case illustrates how courts…
This article discusses the conditions under which using a patented invention in a movie may constitute patent infringement under Indian law. It differentiates between actual use and depiction,…
This article explores the essential requirements for patentability and their function in shaping the boundary between patent protection and the public domain. It discusses the influence of the…
This case review analyses the Garware v Techfeb patent, focusing on the specification's drafting and the relevance of prior art. The post raises questions about the invention's novelty…
This post examines the Garaware vs Techfeb patent dispute, focusing on claim construction and essential features under Indian patent law. It analyses the clarity and novelty of the…
This post analyses the legal function of patent claims in India, focusing on their role as a boundary for inventor rights. It discusses how prosecution history and litigation…
This article examines the challenges in determining software patentability under US and Indian law. It proposes a balanced form and function model to address the shortcomings of current…
The Indian Patent Office often raises morality objections to sexual inventions, particularly in the context of devices and aids. This post analyses such objections, the legal framework under…
Dr. Kalyan C. Kankanala discusses post grant opposition of patents in India, focusing on the legal grounds and procedure under Section 25(2) of the Patent Act. The lecture…
Dr. Kalyan C. Kankanala discusses the pre grant opposition of patents in India, focusing on the legal provisions and grounds available under Section 25(1). The lecture highlights the…